Skip to content
Natraj Proteins logo

Natraj Proteins

530119 BSE
₹36.00

Close ·

P/E
3.03
View as Markdown
MCP
Close 4 Nov 2026 ₹36.00 −3.70 −9.32% 1Y
Start ₹39.70

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
5.63%
Debt to Equity
1.06
EPS (TTM)
₹11.90
Book Value
₹95.49
Market Cap
—
P/E (TTM)
3.03
P/B
0.38
ROE
3.48%
Dividend Yield
0.00%
EBITDA
₹3.90 Cr
52W High
₹45.80
52W Low
₹28.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

50 Average

Data confidence 100/100

Category scores

Quality
31
Poor
Returns, margins, earnings quality 22% weight
Valuation
64
Good
Cheap vs sector & own history 24% weight
Growth
37
Poor
Sales & profit trajectory 9% weight
Financial Health
42
Weak
Solvency, leverage, coverage 9% weight
Momentum
61
Good
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.41 times its book value

Weaknesses

2
  • The company has delivered a poor sales growth of -7.11% over past five years.
  • Company has a low return on equity of -12.1% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
45.77
Neutral
MACD (12,26,9)
−0.78
Bearish
SMA (50)
39.09
Bearish
SMA (200)
36.14
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−6.65%
5Y−7.10%
3Y−11.15%
1Y−14.41%
TTM+0.15%

Net profit

Net profit growth by window
10YTurned to profit
5YZero base
3Y0.00%
1YTurned to profit
TTMTurned to profit

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YTurned negative
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+4.96 pp
5Y+1.91 pp
3Y+1.88 pp
1Y+3.11 pp
TTM+5.26 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹258 Cr
Mar 2018₹196 Cr
Mar 2019₹191 Cr
Mar 2020₹154 Cr
Mar 2021₹146 Cr
Mar 2022₹145 Cr
Mar 2023₹144 Cr
Mar 2024₹194 Cr
Mar 2025₹118 Cr
Mar 2026₹101 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹2.00 Cr
Mar 2019₹1.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹9.00 Cr
Mar 2023₹1.00 Cr
Mar 2024−₹13.00 Cr
Mar 2025−₹1.00 Cr
Mar 2026₹1.00 Cr

Quarterly Results

₹ Cr
530119 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
40.59
36.25
78.04
38.85
38.53
22.79
33.41
23.06
26.56
26.92
28.77
18.87
31.42
Expenses
45.98
41
79.14
36.97
39.51
23.19
32.78
21.19
27.19
27.94
25.23
17.15
28.61
Operating Profit
−5.39
−4.75
−1.1
1.88
−0.98
−0.4
0.63
1.87
−0.63
−1.02
3.54
1.72
2.81
OPM %
−13.28%
−13.1%
−1.41%
4.84%
−2.54%
−1.76%
1.89%
8.11%
−2.37%
−3.79%
12.3%
9.11%
8.94%
Other Income
0.03
0.05
0.03
0.19
0.05
0.06
0.02
0.35
0.07
0.05
0.04
0.1
0.05
Interest
0.68
0.79
0.55
0.93
0.72
0.55
0.5
0.66
0.55
0.58
0.59
0.66
0.63
Depreciation
0.1
0.1
0.11
0.13
0.09
0.09
0.1
0.07
0.09
0.09
0.09
0.11
0.11
PBT
−6.14
−5.59
−1.73
1.01
−1.74
−0.98
0.05
1.49
−1.2
−1.64
2.9
1.05
2.12
Tax %
0.16%
0.18%
2.31%
0%
0%
4.08%
40%
15.44%
0.83%
0.61%
0.34%
−5.71%
0.47%
Net Profit
−6.16
−5.6
−1.76
1
−1.74
−1.01
0.03
1.26
−1.21
−1.65
2.89
1.11
2.11
EPS (₹)
−16.44
−14.95
−4.7
2.67
−4.64
−2.7
0.08
3.36
−3.23
−4.4
7.71
2.96
5.63

Profit & Loss

₹ Cr
530119 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
302
201
258
196
191
154
146
145
144
194
118
101
106
Expenses
296
203
254
189
185
150
143
130
140
203
117
98
99
Operating Profit
6
−2
4
6
6
5
3
14
3
−9
1
4
7
OPM %
2%
−0.9%
1.5%
3.3%
3.1%
2.9%
2.1%
10%
2.2%
−4.8%
0.9%
3.6%
7%
Other Income
1
1
1
0
0
0
0
0
0
0
0
0
0
Interest
5
3
4
4
4
4
2
1
2
3
2
2
2
Depreciation
1
1
1
1
1
1
0
0
0
0
0
0
0
PBT
2
−5
0
2
1
0
1
13
1
−12
−1
1
4
Tax %
11%
0%
25%
10%
16%
−3%
59%
28%
29%
0%
25%
−3%
—
Net Profit
2
−5
0
2
1
0
0
9
1
−13
−1
1
4
EPS (₹)
4.06
−14.17
0.61
4.3
3.07
0.91
1.04
24.98
1.89
−33.41
−3.9
3.04
11.9
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
530119 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
4
4
4
4
4
4
Reserves
34
29
29
31
32
32
32
42
42
30
28
30
Borrowings
43
19
19
54
31
31
22
27
34
40
23
36
Other Liabilities
15
19
14
18
6
4
10
3
9
4
4
7
Total Liabilities
95
71
65
106
72
71
68
76
89
78
59
76
Fixed Assets
6
5
4
4
4
3
3
4
4
5
5
6
CWIP
2
0
0
0
0
0
0
0
2
0
1
0
Investments
0
0
0
0
0
0
0
1
0
0
0
0
Other Assets
87
66
61
102
69
68
66
71
83
72
52
70
Total Assets
95
71
65
106
72
71
68
76
89
78
59
76

Cash Flow

₹ Cr
530119 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
25
9
3
−37
30
2
9
6
3
−6
22
−14
Investing
−2
4
−2
3
2
0
0
−3
−3
0
−2
3
Financing
−13
−27
−4
31
−28
−4
−10
2
−2
3
−20
11
Net Cash Flow
10
−14
−3
−3
4
−2
−2
5
−2
−2
−1
0
Free Cash Flow
24
11
3
−37
29
2
9
4
1
−6
21
−14
CFO/OP
415
−494
67
−583
500
42
264
63
96
60
1,970
−378

Ratios

530119 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
16
10
16
27
38
42
37
43
31
32
28
27
Inventory Days
58
85
55
174
87
108
122
119
154
84
109
207
Days Payable
15
24
16
32
8
5
20
3
18
3
4
17
Cash Conversion Cycle
59
71
55
168
117
145
139
159
167
113
133
217
Working Capital Days
7
32
27
50
50
68
73
81
82
38
54
68
ROCE %
7%
−3%
8%
9%
7%
6%
4%
21%
4%
−12%
2%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Natraj Proteins insights

65 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 50.79%
  • Promoters 41.79%
  • Others 5.51%
  • DIIs 1.90%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Natraj Proteins

What does Natraj Proteins Ltd do?
Incorporated in 1990, Natraj Proteins Ltd deals in Solvent Extraction including Rice Milling and Commodity Trading
Where is Natraj Proteins Ltd (NATRAJPR) listed?
Natraj Proteins Ltd trades under code 530119 on the BSE.
Which sector does Natraj Proteins Ltd belong to?
Natraj Proteins Ltd is classified under the FMCG sector, in the FMCG Products industry.
What is the PE ratio of Natraj Proteins Ltd?
Natraj Proteins Ltd trades at a PE ratio of 3.03 as of 4 Nov 2026, on earnings per share of ₹11.9, against a book value of ₹95.49 per share.
What is the 52-week high and low of Natraj Proteins Ltd?
Over the last 52 weeks Natraj Proteins Ltd has traded between ₹28 and ₹45.8 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Natraj Proteins Ltd?
Natraj Proteins Ltd reported a return on equity of 3.48%. Its debt-to-equity ratio is 1.06.

Company Information

Incorporated in 1990, Natraj Proteins Ltd deals in Solvent Extraction including Rice Milling and Commodity Trading

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530119.md for Natraj Proteins Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More